| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 91396 |
Tetrac-PEG-DSPE , 四碘甲状腺乙酸-聚乙二醇-磷脂 |
170 |
kx |
2024-11-28 |
| 91397 |
(DOTA)5-decalysine ; (DOTA)5-十氢赖氨酸 |
166 |
wyh |
2024-11-28 |
| 91398 |
地塞米松/环糊精骨架复合物 |
186 |
h |
2024-11-28 |
| 91399 |
四嗪修饰9-芴甲醇(TZ-9-Fluorenylmethanol) |
170 |
WYQ |
2024-11-28 |
| 91400 |
DOTA-F(ab′)2-trastuzumab,DOTA-F(ab′)2-曲妥珠单抗 |
181 |
kx |
2024-11-28 |
| 91401 |
四嗪修饰胆甾醇(TZ-Cholesterol,但需注意以下信息主要是关于胆固醇-聚乙二醇-四嗪即Chol-PEG-TZ) |
187 |
WYQ |
2024-11-28 |
| 91402 |
四嗪修饰金刚烷醇(TZ-1-Adamantanol) |
212 |
WYQ |
2024-11-28 |
| 91403 |
环糊精类金属有机框架负载姜黄素 CurCDMOFs |
256 |
h |
2024-11-28 |
| 91404 |
DOTA-PEG(2)-DTyr-Gln-Trp-Ala-Val-bAla-His-Phe-Nle-NH2 ,DOTA肽缀合物 |
155 |
kx |
2024-11-28 |
| 91405 |
DOTA-(Tyr3)-Octreotate acetate salt |
153 |
zyl |
2024-11-28 |
| 91406 |
四嗪类高氮含能化合物3,6-双(1H-1,2,3,4-四唑-5-氨基)-s-四嗪 |
154 |
WYQ |
2024-11-28 |
| 91407 |
DOTA-TCTP-1 , DOTA偶联TCTP-1多肽 |
182 |
kx |
2024-11-28 |
| 91408 |
1-[6-(3,5-二甲基-1H-吡唑-1-基)-1,2,4,5-四嗪-3-基]酰肼 |
149 |
WYQ |
2024-11-28 |
| 91409 |
3-胍基-6(3,5-二甲基吡唑)-1,2,4,5-四嗪高氯酸盐甲醇合物(BGTz·HClO4·CH3OH) |
137 |
WYQ |
2024-11-28 |
| 91410 |
钬-DOTA复合物 , Holmium-DOTA |
275 |
kx |
2024-11-28 |
| 91411 |
DOTA-tris(TBE)-amido dPEG-MAL |
180 |
zyl |
2024-11-28 |
| 91412 |
DOTA-monoamide ;DOTA-单酰胺复合物 |
167 |
wyh |
2024-11-28 |
| 91413 |
DOTA-PEG(23)-bromoacetamide*2TFA |
237 |
zyl |
2024-11-28 |
| 91414 |
DOTA-BASS;DOTA偶联sst拮抗剂 |
153 |
wyh |
2024-11-28 |
| 91415 |
DOTA-赖氨酸 , DOTA-lysine |
141 |
kx |
2024-11-28 |
| 91416 |
DOTA(tBu3)-PEG(4)-TFP |
291 |
zyl |
2024-11-28 |
| 91417 |
DOTA-phenylalanine;DOTA-苯丙氨酸 |
132 |
wyh |
2024-11-28 |
| 91418 |
NOTA-抗CTLA-4单克隆抗体 , DOTA-抗CTLA-4mAb |
180 |
kx |
2024-11-28 |
| 91419 |
金属螯合剂DOTA偶联α-MSH类似物 |
189 |
wyh |
2024-11-28 |
| 91420 |
Gd-DOTA-c(RGD-ACH-K), 氨基环己烷偶联Gd-DOTA(钆-四氮杂环十二烷四乙酸)和环状RGDK肽 |
143 |
kx |
2024-11-28 |
| 91421 |
DOTA-MBA;1,4,7,10-四氮杂-4,7,10-三甲基-环十二烷基-R-(+)-α-甲基苄胺 |
156 |
wyh |
2024-11-28 |
| 91422 |
DOTA-唑来膦酸结合物 , DOTA-zoledronate conjugate |
144 |
kx |
2024-11-28 |
| 91423 |
β环糊精聚乙烯亚胺修饰碳量子点 PEI-β-CyD/CDs |
196 |
h |
2024-11-28 |
| 91424 |
DOTA−Lysine−Biotin ;DOTA -赖氨酸-生物素 |
156 |
wyh |
2024-11-28 |
| 91425 |
氮掺杂碳量子点/银纳米粒子/β-环糊精复合材料 N-CQDs/AgNPs/β-CD |
176 |
h |
2024-11-28 |
| 91426 |
DOTA缀合(+)-生物素二聚体, DOTA conjugated (+)-biotin |
119 |
kx |
2024-11-28 |
| 91427 |
DOTA-8-Aoc-BBN[7–14]NH |
165 |
wyh |
2024-11-28 |
| 91428 |
DOTA-MSOct的性质 |
146 |
wyh |
2024-11-28 |
| 91429 |
β-环糊精官能化的氮掺杂石墨烯量子点 βCDNGQDs |
150 |
h |
2024-11-28 |
| 91430 |
DOTA-PSMA-EB-01 |
170 |
zyl |
2024-11-28 |
| 91431 |
DOTA-capsaicin, DOTA-辣椒碱 |
165 |
kx |
2024-11-28 |
| 91432 |
CAS:1800229-46-2 Maleimide-DOTA-GA |
160 |
zyl |
2024-11-28 |
| 91433 |
β-环糊精修饰碳量子点 β-CD-CQDs |
181 |
h |
2024-11-28 |
| 91434 |
DOTA-IAC的组成和结构、功能与应用 |
224 |
kx |
2024-11-28 |
| 91435 |
环糊精纳米海绵-石墨烯量子点-多壁碳管复合物 CDNS/GQDs/MWCNTs-COOH |
201 |
h |
2024-11-28 |
| 91436 |
DOTA-三(酸) - 酰氨基-DPEG(R)11-马来酰亚胺 |
156 |
zyl |
2024-11-28 |
| 91437 |
DOTA-2IT-m170 ;金属螯合物DOTA偶联单克隆抗体m170 |
209 |
wyh |
2024-11-28 |
| 91438 |
β-环糊精修饰Mn-ZnS量子点 β-CD@Mn-ZnS QDs |
161 |
h |
2024-11-28 |
| 91439 |
DOTA-抗ROBO1单克隆抗体 ; 1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸(DOTA)缀合抗ROBO1单克隆抗体 |
184 |
kx |
2024-11-28 |
| 91440 |
水溶性β-环糊精修饰的金量子点 β-CD-Au QDs |
146 |
h |
2024-11-28 |